Bioxyne’s immune-boosting probiotic sees a growth in Asia sales
Science research company Bioxyne, has had a positive September quarter, reporting strong…
Bioxyne Limited (ASX:BXN)
About Bioxyne Limited
Key Information
BXN In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/11/2023 | Final Director's Interest Notice | 141.7KB | 87 |
| 17/11/2023 | Price Sensitive PS Retirement of Director | 564.48KB | 121 |
| 17/11/2023 | Results of Meeting | 586.31KB | 107 |
| 17/11/2023 | Annual General Meeting Presentation | 7.69MB | 105 |
| 06/11/2023 | Change in substantial holding | 156.14KB | 110 |
| 31/10/2023 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 988.5KB | 131 |
| 19/10/2023 | BLS Builds Medicinal Business In Australia | 614.62KB | 161 |
| 18/10/2023 | Letter to Shareholders re Annual General Meeting Notice | 608.01KB | 101 |